Atıf Formatları
Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. ÖZBEY Et Al. , "Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation," PHARMACOLOGICAL REPORTS , vol.72, no.5, pp.1397-1406, 2020

ÖZBEY, G. Et Al. 2020. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. PHARMACOLOGICAL REPORTS , vol.72, no.5 , 1397-1406.

ÖZBEY, G., NEMUTLU-SAMUR, D., PARLAK, H., YILDIRIM, S., Aslan, M., TANRIÖVER, G., ... Agar, A.(2020). Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. PHARMACOLOGICAL REPORTS , vol.72, no.5, 1397-1406.

ÖZBEY, GÜL Et Al. "Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation," PHARMACOLOGICAL REPORTS , vol.72, no.5, 1397-1406, 2020

ÖZBEY, GÜL Et Al. "Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation." PHARMACOLOGICAL REPORTS , vol.72, no.5, pp.1397-1406, 2020

ÖZBEY, G. Et Al. (2020) . "Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation." PHARMACOLOGICAL REPORTS , vol.72, no.5, pp.1397-1406.

@article{article, author={GÜL ÖZBEY Et Al. }, title={Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation}, journal={PHARMACOLOGICAL REPORTS}, year=2020, pages={1397-1406} }